Genetic roadmap could revolutionize AML treatment for older adults
NCT ID NCT03013998
First seen Jan 06, 2026 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study aims to see if quickly analyzing the genetic makeup of a person's leukemia can help doctors choose the best targeted therapy for them. It involves 3,000 adults, mostly aged 60 and older, with newly diagnosed or returning acute myeloid leukemia (AML). Participants receive treatments based on their specific genetic markers, with the goal of improving response rates and advancing new drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREVIOUSLY UNTREATED RELAPSED REFRACTORY ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University
RECRUITINGAtlanta, Georgia, 30308, United States
Contact
-
Huntsman Cancer Institute, University of Utah
COMPLETEDSalt Lake City, Utah, 84112, United States
-
Mayo Clinic Arizona
COMPLETEDPhoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
COMPLETEDJacksonville, Florida, 32224, United States
-
Mayo Clinic Minnesota
COMPLETEDRochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Contact
-
Oregon Health & Science University
RECRUITINGPortland, Oregon, 97239, United States
Contact
-
UCLA Ronald Reagan Medical Center
RECRUITINGLos Angeles, California, 90095, United States
Contact
-
UNC Hospitals, University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27514, United States
Contact
-
UPMC Hillman Cancer Center
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Contact
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact
-
University of Cincinnati Medical Center
RECRUITINGCincinnati, Ohio, 45219, United States
Contact
-
University of Colorado
COMPLETEDDenver, Colorado, 80203, United States
-
University of Florida Health Shands Cancer Hospital
COMPLETEDGainesville, Florida, 32608, United States
-
University of Kansas Clinical Research Center
RECRUITINGFairway, Kansas, 66205, United States
Contact
-
University of Maryland Medical Center
RECRUITINGBaltimore, Maryland, 21201, United States
Contact
-
University of Texas Southwestern
RECRUITINGDallas, Texas, 75390, United States
Contact
Conditions
Explore the condition pages connected to this study.